Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038

High density synthetic oligonucleotide arrays

Lipshutz, R. J., Fodor, S. P. A., Gingeras, T., & Lockhart, D. J. (1999) · Nature Genetics · doi:10.1038/4447 · Cited by 2,204

Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories

Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656

Gene-expression profile of the ageing brain in mice

Lee, C.-K., Weindruch, R., & Prolla, T. A. (2000) · Nature Genetics · doi:10.1038/77046 · Cited by 1,055

Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond

Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909

Importance of replication in microarray gene expression studies: Statistical methods and evidence from repetitive cDNA hybridizations

Lee, M. T., Kuo, F. C., Whitmore, G. A., & Sklar, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.9834 · Cited by 861

Kainic Acid-Mediated Excitotoxicity as a Model for Neurodegeneration

Wang, Q., Yu, S. O., Simonyi, Á., Sun, G. Y., & Sun, A. Y. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:003 · Cited by 365

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

Grünblatt, E., Mandel, S. A., Jacob‐Hirsch, J., Zeligson, S., Amariglo, N., Rechavi, G., Li, J., Ravid, R., Roggendorf, W., Riederer, P. F., et al. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0212-1 · Cited by 355

Pattern of brain destruction in Parkinson's and Alzheimer's diseases

Braak, H., Braak, E., Yilmazer‐Hanke, D., de Vos, R. A. I., Jansen, E. N. H., & Böhl, J. (1996) · Journal of Neural Transmission · doi:10.1007/bf01276421 · Cited by 326

Computational methods for theidentification of differential and coordinated gene expression

Claverie, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.10.1821 · Cited by 287

Kallistatin leads to cognition impairment via downregulating glutamine synthetase

Long, Y., Zhao, Z., Xie, W., Shi, J., Yang, F., Zhu, D., Jiang, P., Tang, Q., Zhou, T., Jiang, B., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107145 · Cited by 17

Hibiscus sabdariffa extract protects HT-22 cells from glutamate-induced neurodegeneration by upregulating glutamate transporters and exerts lifespan extension in C. elegans via DAF-16 mediated pathway

Malar, D. S., Prasanth, M. I., Brimson, J. M., Verma, K., Prasansuklab, A., & Tencomnao, T. (2021) · Nutrition and Healthy Aging · doi:10.3233/nha-210131 · Cited by 18

Progress in mechanisms of acetylcholinesterase inhibitors and memantine for the treatment of Alzheimer's disease

Xu, P., Li, S., & Mo, M. (2015) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.167305 · Cited by 18

Hippocampal Synaptic Dysfunction in a Mouse Model of Huntington Disease Is Not Alleviated by Ceftriaxone Treatment

Wilkie, C. M., Barnes, J. R., Benson, C.-L. M., Brymer, K. J., Nafar, F., & Parsons, M. P. (2020) · eNeuro · doi:10.1523/eneuro.0440-19.2020 · Cited by 17

The Role of Astrocytes in Synaptic Dysfunction and Memory Deficits in Alzheimer’s Disease

de León-López, C. A. M., Navarro‐Lobato, I., & Khan, Z. U. (2025) · Biomolecules · doi:10.3390/biom15070910 · Cited by 19

Cortical Hyperexcitability in the Driver’s Seat in ALS

Gunes, Z. I., Kan, V. W. Y., Jiang, S., Logunov, E., Ye, X., & Liebscher, S. (2022) · Clinical and Translational Neuroscience · doi:10.3390/ctn6010005 · Cited by 18

WNT/β-catenin Pathway: a Possible Link Between Hypertension and Alzheimer’s Disease

Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01209-1 · Cited by 16

PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Aβ42 toxicity

Yu, Y., Niccoli, T., Ren, Z., Woodling, N. S., Aleyakpo, B., Szabadkai, G., & Partridge, L. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa125 · Cited by 19

Genistein inhibits amyloid peptide 25-35-induced neuronal death by modulating estrogen receptors, choline acetyltransferase and glutamate receptors

Wang, Y., Xia, Z., Jiang, X., Li, L., Wang, H., An, D., & Liu, Y. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108561 · Cited by 16

Genome-wide analysis of hippocampal transfer RNA-derived small RNAs identifies new potential therapeutic targets of Bushen Tiansui formula against Alzheimer’s disease

Zhang, Z.-Y., Zhang, C., Yang, J., Xu, P.-P., Yi, P., Hu, M., & Peng, W. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.12.005 · Cited by 16

Road to Alzheimer’s Disease: The Pathomechanism Underlying

Anand, R., Kaushal, A., Wani, W. Y., & Gill, K. D. (2011) · Pathobiology · doi:10.1159/000332218 · Cited by 16

Neuroprotective role of GLT-1/EAAT2 in glutamate-induced excitotoxicity

Zhang, Y., Liu, W., Huang, T., Liu, L., & Chen, X. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115804 · Cited by 15

Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice

Nilsson, P., Loganathan, K., Sekiguchi, M., Winblad, B. G., Iwata, N., Saido, T. C., & Tjernberg, L. O. (2015) · PROTEOMICS · doi:10.1002/pmic.201400211 · Cited by 14

Structural basis for the interaction between dynein light chain 1 and the glutamate channel homolog GRINL1A

García‐Mayoral, M. F., Martínez‐Moreno, M., Albar, J. P., Rodríguez‐Crespo, I., & Bruix, M. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07649.x · Cited by 14

Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Aβ-bearing fragment is associated with reduced NMDA receptor density

Boon, W. C., van den Buuse, M., Wegener, N., Martin, S., Chua, H. K., Bush, A. I., Masters, C. L., Adlard, P. A., & Li, Q. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.013 · Cited by 14

APPswe mutation increases the frequency of spontaneous Ca2+-oscillations in rat hippocampal neurons

Kloskowska, E., Małkiewicz, K., Winblad, B. G., Benedikz, E., & Bruton, J. D. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.034 · Cited by 14

Ceftriaxone Relieves Trigeminal Neuropathic Pain Through Suppression of Spatiotemporal Synaptic Plasticity via Restoration of Glutamate Transporter 1 in the Medullary Dorsal Horn

Luo, X. L., He, T., Wang, Y., Wang, J., Yan, X., Zhou, H., Wang, R., Du, R., Wang, X., Chen, J., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00199 · Cited by 13

Sulbactam protects neurons against double neurotoxicity of amyloid beta and glutamate load by upregulating glial glutamate transporter 1

Li, L., Li, W., Jiang, W., & Xu, R. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01827-5 · Cited by 13

4-Hydroxyhexenal (HHE) Impairs Glutamate Transport in Astrocyte Cultures

Lovell, M. A., Bradley‐Whitman, M. A., & Fister, S. X. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120409 · Cited by 15

Positive allosteric activation of glial EAAT-2 transporter protein: A novel strategy for Alzheimer’s disease

Manisha, C., Ayyamperumal, S., Selvaraj, J., Nanjan, C. M. J., Joghee, N. M., Clement, J. P., & Justin, A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109794 · Cited by 13

Cerebral Level of vGlut1 is Increased and Level of Glycine is Decreased in TgSwDI Mice

Timmer, N., Metaxas, A., van der Stelt, I., Kluijtmans, L. A. J., van Berckel, B. N. M., & Verbeek, M. M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130437 · Cited by 13

An astrocyte-microglia MFG-E8 axis promotes synapse engulfment in early amyloid pathology

Sokolova, D., Puletti, F., Ghansah, S. A., Georgiades, T., Zheng, Y., Wu, L., Schepper, S. D., Lange, J., Ferreira, L. S. S., Sierksma, A., et al. (2026) · Neuron · doi:10.1101/2024.08.31.606944 · Cited by 15

Compromised Astrocyte Swelling/Volume Regulation in the Hippocampus of the Triple Transgenic Mouse Model of Alzheimer’s Disease

Turečková, J., Kamenická, M., Koleničová, D., Filipi, T., Heřmanová, Z., Kriška, J., Mészárošová, L., Pukajova, B., Valihrach, L., Androvic, P., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.783120 · Cited by 12

Neuronal MML-1/MXL-2 regulates systemic aging via glutamate transporter and cell nonautonomous autophagic and peroxidase activity

Shioda, T., Takahashi, I., Ikenaka, K., Fujita, N., Kanki, T., Oka, T., Mochizuki, H., Antebi, A., Yoshimori, T., & Nakamura, S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221553120 · Cited by 12

Atorvastatin Prevents Glutamate Uptake Reduction Induced by Quinolinic Acid Via MAPKs Signaling

Vandresen-Filho, S., Martins, W. C., Bertoldo, D. B., Rieger, D. K., Maestri, M., Leal, R. B., & Tasca, C. I. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1913-1 · Cited by 12

GLT1 gene delivery based on bone marrow-derived cells ameliorates motor function and survival in a mouse model of ALS

Ohashi, N., Terashima, T., Katagi, M., Nakae, Y., Okano, J., Suzuki, Y., & Kojima, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-92285-x · Cited by 13

Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases

Volonté, C., Hu, G., Shaw, C. A., Claudio, V. J., dos Santos, J. A., Vaz, S. H., Sebastião, A. M., Balcar, V. J., Mozley, P. D., Verde, F., et al. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004136 · Cited by 12

Impaired astrocytic synaptic function by peripheral cholesterol metabolite 27-hydroxycholesterol

Spanos, F., Gerenu, G., Goikolea, J., Latorre-Leal, M., Balleza-Tapia, H., Gomez, K., Álvarez-Jiménez, L., Piras, A., Gómez-Galán, M., Fisahn, A., et al. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1347535 · Cited by 10

Alzheimer’s disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity

Pavešković, M., De-Paula, R. B., Ojelade, S. A., Tantry, E. K., Kochukov, M. Y., Bao, S., Veeraragavan, S., Garza, A. R., Srivastava, S., Song, S., et al. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae115 · Cited by 11

Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers

Scaduto, P., Marcatti, M., Bhatt, N. N., Kayed, R., & Taglialatela, G. (2024) · Brain Communications · doi:10.1093/braincomms/fcae277 · Cited by 11

Selective disruption of synaptic NMDA receptors of the hippocampal trisynaptic circuit in Aβ pathology

Alfaro‐Ruiz, R., Martín‐Belmonte, A., Aguado, C., Moreno‐Martínez, A. E., Fukazawa, Y., & Luján, R. (2024) · Biological Research · doi:10.1186/s40659-024-00537-7 · Cited by 12

Are Hippocampal Hypoperfusion and ATP Depletion Prime Movers in the Genesis of Alzheimer’s Disease? A Review of Recent Pertinent Observations from Molecular Biology

Walker, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157328 · Cited by 11

Ecdysterone and High-Intensity Interval Training Mitigate Alzheimer’s Pathology in Rats: Impacts on Depression, Synaptic Plasticity, and Neuroinflammation

Gholipour, P., Komaki‬, A., Parsa, H., & Ramezani, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05168-x · Cited by 10

Glutamatergic and GABAergic metabolite levels in Alzheimer’s disease: a systematic review and meta-analysis

Ebrahimi, R., Soltani, S. M., Masouri, M. M., Seifi, M., Ghafourian, K., & Noori, S. (2025) · BMC Neurology · doi:10.1186/s12883-025-04375-2 · Cited by 11

Chemogenetic manipulation of astrocyte activity at the synapse— a gateway to manage brain disease

Pereira, M. J., Ayana, R., Holt, M. G., & Arckens, L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1193130 · Cited by 10

Astrocyte–Neuron Communications

McIver, S. R., Faideau, M., & Haydon, P. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_2 · Cited by 12

Specialized Neurotransmitter Transporters in Astrocytes

Yang, Y., & Rothstein, J. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-79492-1_4 · Cited by 9

Ferroptosis and retinal ganglion cell death in glaucoma: Mechanisms and therapeutic approaches

Qin, M., He, X., Qiu, W., Peng, Y., Liao, Y., Zhao, J., Luo, L., & Zhang, Q. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101355 · Cited by 9

The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential

Abedin, M. J., & Kastanenka, K. V. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251411561 · Cited by 9

Fast Interneuron Dysfunction in Laminar Neural Mass Model Reproduces Alzheimer's Oscillatory Biomarkers

Sanchez-Todo, R., Mercadal, B., Lopez-Sola, E., Guasch-Morgades, M., Deco, G., & Ruffini, G. (2026) · Human Brain Mapping · doi:10.1002/hbm.70428 · Cited by 9

The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease

de Lima, I. B. Q., & Ribeiro, F. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x20666211223140303 · Cited by 9

Unveiling the Interplay: Neurovascular Coupling, Astrocytes and G Protein-Coupled Receptors in Alzheimer’s Disease

Al-Jaf, S., Soliman, A. Y., EL‐Yazbi, A. F., & Abd‐Elrahman, K. S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00614 · Cited by 8

Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer’s disease

Liu, L.-Z., Fan, S., Gao, J., Li, W., & Xian, X. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110683 · Cited by 9

Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats

Grünblatt, E., Schmidt, W., Scheller, D., Riederer, P. F., & Gerlach, M. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0552-y · Cited by 8

Astrocyte response in Alzheimer’s disease: Good or bad?

Ismail, A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Yassen, A. S. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149971 · Cited by 6

Role of dysregulated calcium homeostasis in astrocytes in neurodegenerative disorders

Sanchez-Mico, M. V., Calvo-Rodríguez, M., & Bacskai, B. J. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01032-6 · Cited by 9

Cholesterol‐24‐hydroxylase (CYP46) in the old brain: Analysis of positive populations and factors triggering its expression in astrocytes

Cataldi, G. G., Elorza, S. D., Toledano‐Zaragoza, A., de Olmos, S., Cragnolini, A. B., & Martín, M. G. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25436 · Cited by 9

Impairment of hippocampal long-term potentiation by soluble amyloid-β oligomers is mediated by glutamate transporter 1 expressed in neurons

Li, S., Wang, J., Guo, Q., Bai, Y., Liu, W., Hodgetts, K. J., Rosenberg, P. A., & Selkoe, D. J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00882 · Cited by 6

Phosphonate analog of 2-oxoglutarate regulates glutamate-glutamine homeostasis and counteracts amyloid beta induced learning and memory deficits in rats

Sayehmiri, F., Khodagholi, F., Pourbadie, H. G., Naderi, N., Aliakbarzadeh, F., Hashemi, R., Naderi, S., & Motamedi, F. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111944 · Cited by 6

Transcriptome analysis reveals potential marker genes for diagnosis of Alzheimer’s disease and vascular dementia

Wang, L., Yu, C., Tao, Y., Yang, X., Jiang, Q., Yu, H., & Zhang, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1038585 · Cited by 8

PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

Perrin, F., Anderson, L. C., Mitchell, S. P. C., Sinha, P., Turchyna, Y., Maesako, M., Houser, M. C., Zhang, C. M., Wagner, S. L., Tanzi, R. E., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01876-y · Cited by 6

Reactive Astrocytes with Reduced Function of Glutamate Transporters in the App NL-G-F Knock-in Mice

Srivastava, I., Goikolea, J., Kaya, T. A., Latorre‐Leal, M., Eroli, F., Iglesias, M. P., Álvarez-Jiménez, L., Arroyo‐García, L. E., Shimozawa, M., Nilsson, P., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00714 · Cited by 8

The NMDAR/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer’s disease

Yan, J., Yang, X., Li, G., Ramírez, O. A., Hagenston, A. M., Chen, Z.-Y., & Bading, H. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03143-5 · Cited by 6

Glutamate and Neurodegenerative Disease

Schaeffer, E., & Duplantier, A. J. (2010) · Topics in medicinal chemistry · doi:10.1007/7355_2010_11 · Cited by 5

Genome scan in familial late‐onset Alzheimer's disease: A locus on chromosome 6 contributes to age‐at‐onset

Zhao, W., Blue, E., Cheung, C. Y. K., Steinbart, E. J., Schellenberg, G. D., Bird, T. D., & Wijsman, E. M. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32133 · Cited by 5

The Role of Caffeine in Neurodegenerative Diseases

Lương, K. V. Q., & Nguyễn, L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00028-x · Cited by 5

Upregulated excitatory amino acid transporter 1 (EAAT1) expression in the human medial temporal lobe in Alzheimer’s disease

Wood, O. W. G., Yeung, J. H. Y., Palpagama, T. H., Turner, C. P., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.027 · Cited by 5

Single-Cell Transcriptomic Profiling Reveals Regional Differences in the Prefrontal and Entorhinal Cortex of Alzheimer’s Disease Brain

Niu, R., Feng, W.-Q., Chen, L., & Bao, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104841 · Cited by 5

ABCA7 deficiency exacerbates glutamate excitotoxicity in Alzheimer’s disease mice – A new pharmacological target for Glu-related neurotoxicity

Górska, A. M., Santos‐García, I., Kvasnička, A., Dobešová, D., Friedecký, D., Gildenblat, J., & Pahnke, J. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102891 · Cited by 6

Framework for reanalysis of publicly available Affymetrix® GeneChip® data sets based on functional regions of interest

Saka, E., Harrison, B. J., West, K. L., Petruska, J. C., & Rouchka, E. C. (2017) · BMC Genomics · doi:10.1186/s12864-017-4266-5 · Cited by 5

Aryl Hydrocarbon Receptor in Glia Cells: A Plausible Glutamatergic Neurotransmission Orchestrator

Silva-Parra, J., Sandu, C., Felder‐Schmittbuhl, M., Hernández‐Kelly, L. C., & Ortega, A. (2023) · Neurotoxicity Research · doi:10.1007/s12640-022-00623-2 · Cited by 4

Development of PET and SPECT Radioligands for In Vivo Imaging of NMDA Receptors

Fuchigami, T., Nakayama, M., & Magata, Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_19 · Cited by 4

Emerging Roles for Glial Pathology in Addiction

Reissner, K. J., & Kalivas, P. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_17 · Cited by 4

Amino Acid Transporters Proteins Involved in the Glutamate-Glutamine Cycle and Their Alterations in Murine Models of Alzheimer’s Disease

Vázquez-Durán, D. L., Ortega, A., & Rodríguez, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03966-3 · Cited by 4

Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders

Escamilla, S., Pérez‐González, R., Márquez‐Marco, C., Camporesi, E., Brinkmalm, G., Padovani, A., Pilotto, A., Tolassi, C., Arici, D., Volonghi, I., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70192 · Cited by 3

The Use of DREADDs for Dissecting the Contribution of Cellular and Neural Circuit Mechanisms in Models of Neurodegenerative Disease

Sharma, P., & Pienaar, I. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-804078-2.00024-6 · Cited by 3

Protein Carbonylation in Brains of Subjects with Selected Neurodegenerative Disorders

Reed, T. T., & Butterfield, D. A. (2017) · Wiley eBooks · doi:10.1002/9781119374947.ch8 · Cited by 3

The rise and deceleration of neuronal excitability in aging and Alzheimer’s disease: Mechanisms, implications, and therapeutic targets

Delbono, O., Wang, Z., & Messi, M. L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102999 · Cited by 3

Glutamate stress in the caudal nucleus tractus solitarii (nTS): Impact on respiratory function and synaptic signaling in an Alzheimer's disease model

Carter, S., Tipton, R. K., Forman, C. M., Mosher, A. P., Ostrowski, D., & Ostrowski, T. D. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115190 · Cited by 2

Astrocyte Glutamate Transporter EAAT2 in Alzheimer Dementia

Kurkinen, M. T. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_7 · Cited by 2

LRP4+ Astrocytes: A Unique Subpopulation Crucial for Blood Vessel Maintenance and Function in the Somatosensory Cortex of Normal and 5xFAD Mice

Arzola, E. P., Yu, G., Xiong, L., Lee, D., Wu, A., Paruchuri, S., Skinner, J., Wang, M., Zhang, B., Mei, L., et al. (2025) · Glia · doi:10.1002/glia.70114 · Cited by 1

Metabolomic Analysis of Aqueous Humor to Predict Glaucoma Progression and Overall Survival After Glaucoma Surgery—The MISO II Study

Detremmerie, L., Sava, A. C., Himmelreich, U., Stalmans, I., Eijgen, J. V., & Barbosa‐Breda, J. (2026) · Metabolites · doi:10.3390/metabo16020100 · Cited by 1

The quest for treatment of cognitive impairment: AMPA and mGlu5 receptor modulators

Sun, M. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.9.999 · Cited by 1

Yi-Chi-Tsung-Ming-Tang Reduced A?(1-40)-induced Neurotoxicity via of Acetylcholine and NMDA Receptors Expression, ROS Generation and Tau Phosphorylation

Yeh, C., Huang, H. C., Chang, K. S., Chen, C. J., Yang, M., Tsai, S.-L., Lin, H., & Kuan, Y. (2017) · Indian Journal of Pharmaceutical Sciences · doi:10.4172/pharmaceutical-sciences.1000244 · Cited by 1

A Network-Based Framework for Mining High-Level Imaging Genetic Associations

Liang, H., Meng, X., Chen, F., Zhang, Q., Yan, J., Yao, X., Kim, S., Wang, L., Feng, W., Saykin, A. J., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813968-4.00007-9 · Cited by 1

Role of Reactive Astrocytes in Alzheimer’s Disease

Sarkar, S., Guha, S., & Biswas, S. C. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_9 · Cited by 1

From postsynaptic neurons to astrocytes: the link between glutamate metabolism, Alzheimer’s disease and Parkinson’s disease

Liu, F.-W., Zhang, X.-R., Cong, Y.-F., Liu, Y., Zhang, H., & Hou, X. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0143 · Cited by 1

Pathological Synaptic Plasticity in Neurological Disorders

Jin, C., & Karlstedt, K. (2025) · Synaptic Plasticity - Neurobiology, Neuroanatomy, and Clinical Neuroscience · doi:10.5772/intechopen.1007753 · Cited by 1

Ceftriaxone ameliorates tau phosphorylation and mislocalization in APP/PS1 AD mice by inhibiting endoplasmic reticulum stress

Feng, N.-N., Li, L., Liu, L.-Z., He, R.-B., Xian, X., Liu, L.-R., Hu, Y.-Y., & Li, W. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110600 · Cited by 1

TRPM2 in the Central Nervous System: Physiological Role and Critical Regulatory Pathways

Belrose, J. C. (2012) · Scholarship@Western (Western University) · Cited by 1

An increased excitation and inhibition onto CA1 pyramidal cells sets the path to Alzheimer’s diseasePreprint

Wehrle, P. H., Rathwell, T. J., Petroccione, M. A., Caiazza, E. D., Manning, A. K., dos Reis, L. F., Todd, G. C., Affinnih, N., Ahmad, S., Mehdi, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.27.656417 · Cited by 1

Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease

Chimal-Juárez, E., Patel, H., Jury-Garfe, N., Dabin, L. C., Vidal, R., Kim, J., & Lasagna-Reeves, C. A. (2026) · bioRxiv · doi:10.64898/2026.05.12.724684

Alterações neurogliais em ratos expostos ao ácido ocadáico como modelo de demência

Costa, A. P. (2011) · Americanae (AECID Library)

Development of Radioligands for In Vivo Imaging of NMDA Receptors

Fuchigami, T., Nakayama, M., & Magata, Y. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_18

Abeta(1-42) enhances neuronal excitability and disrupts synaptic plasticity by altering glutamate-recycling

Varga, E. (2015) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2588

The GluK4 Kainate Receptor Subunit Regulates Mood, Memory and Excitotoxic Neurodegeneration

Lowry, E. R. (2025) · Digital Commons - RU (Rockefeller University) · doi:10.48496/jf25-wz42

Targeting Astrocytes With Viral Gene Therapy for Alzheimer’s Disease

Rosenthal, Z. P., Kraft, A. W., Czerniewski, L. R., & Lee, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00005-3

Alzheimer’s Dementia Drug Discovery

Kurkinen, M. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00044-0

Diet and Nutrition in Alzheimer’s Disease and Healthy Aging

Bule, M. H., Shah, M. A., Abdurahman, A. A., Ullah, M. S., Shah, S., Amin, A., & Niaz, K. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_3

Reducing miR485-3p ameliorates Alzheimer`s disease pathology by regulation of amyloid beta and neuro-inflammationPreprint

Koh, H. S., Jang, H. J., Tae, S., Lee, M.-S., Min, J.-W., Mun, H.-J., Lee, J. N., Lee, H. J., Kim, D. H., Cho, H.-J., et al. (2020) · doi:10.21203/rs.3.rs-19583/v1

Hippocampal Glutamate Level and Glutamate Aspartate Transporter (GLAST) are Up-Regulated in Senior Rat Associated with Isoflurane-Induced Spatial Learning/Memory Impairment

XuHui, X. Q., Xu, W., LiuYun, W., XuChao, Z., & Yue, J. W. (2013)

Clinical Validation of Neuronal Pentraxin Receptor as a Candidate Biomarker for Alzheimer’s Disease

Lim, B. (2020) · TSpace (University of Toronto)

Customer Loyalty in E-Business.

Raggad, B. G., & Lawler, J. E. (2003) · International Conference on Enterprise Information Systems

Reducing miR485-3p ameliorates Alzheimer`s disease pathology by regulation of amyloid beta and neuro-inflammationPreprint

Koh, H. S., Jang, H. J., Tae, S., Lee, M.-S., Min, J.-W., Mun, H.-J., Lee, J. N., Lee, H. J., Dae Hoon, K. I. M., Cho, H., et al. (2020) · doi:10.21203/rs.3.rs-21918/v1

Astrocytic modulation of the synaptic and the extrasynaptic space

Badia‐Soteras, A. (2023) · doi:10.5463/thesis.127

Traversing Through the Trajectory of Pathogenic Astrocytes in Alzheimer’s Disease

Shareena, G., Kumar, D., & Wu, D. H. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_8

Застосування мемантину гідрохлориду у хворих похилого віку на початкових стадіях судинної деменції і хвороби Альцгеймера

Bachynska, N. Y., Rozheliuk, I., Polietaieva, K. M., & Kholin, V. O. (2013) · Likarska sprava · doi:10.31640/ls-2013-7-15

Abordajes terapéuticos en modelos experimentales de la Enfermedad de Alzheimer: potencial antiinflamatorio y neuroprotector de la transferencia génica y celular

Hanotte, J. L. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/161150

Cognitive Function Involving Glial Cells

Boulbaroud, S., Khalki, H., & Azzaoui, F.-Z. (2023) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-6684-9675-6.ch003

Transcriptional and synaptic regulation of NMDA glutamate receptor-mediated hippocampal plasticity and memoryPreprint

Parra‐Damas, A., del Ser‐Badia, A., Fernandez-Olalla, X., Deprada-Fernandez, Á., Enríquez-Barreto, L., Prius-Mengual, J., Català-Solsona, J., Brito, V., Rodrı́guez-Álvarez, J., Ginés, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.19.633774

Neuronal Expression of Splice Variants of “Glial” Glutamate Transporters in Brains Afflicted by Alzheimer’s Disease: Unmasking an Intrinsic Neuronal Property

Pow, D. V., & Cook, D. G. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9957-0 · Cited by 26

Amyloid‐beta1–42 induced glutamatergic receptor and transporter expression changes in the mouse hippocampus

Yeung, J. H. Y., Guzmán, B. C., Palpagama, T. H., Ethiraj, J., Zhai, Y., Tate, W. P., Peppercorn, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15099 · Cited by 24

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease

Yeung, J. H. Y., Palpagama, T. H., Wood, O. W. G., Turner, C. P., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.702824 · Cited by 26

Issue Cover (October 2020)

(2020) · Journal of Neurochemistry · doi:10.1111/jnc.14763 · Cited by 1

P3–199: The glutamate transporter, EAAT3 (EAAC1), is aberrantly expressed in hippocampus of individuals with Alzheimer's disease

Cook, D. G., Deurson, K., Leverenz, J. B., Bird, T. D., Montine, T. J., & Pow, D. V. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1467